Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Zahabia Adnan, Syed Ibad Hussain, Amna Amir Jalal, Ayesha Shaukat, Eisha Abid, Muhammad Burhan, Arsalan Ahmed, Eshal Saghir, Shaikh Muhammad Daniyal, Shanza Shakir, Abedin Samadi, Ahmed Asad Raza, Department of Medicine, Jinnah Sindh Medical University, Department of Medicine, Dow University of Health Sciences, Department of Medicine, Liaquat University of Medical and Health Sciences, Department of Medicine, Kabul University of Medical Sciences Abu Ali Sina

Clinical and Applied Thrombosis/Hemostasis

Published online on June 11, 2026

Abstract

Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
IntroductionVenous thromboembolism (VTE), which includes DVT and PE is a serious complication in cancer patients. This meta-analysis evaluates the efficacy and safety of rivaroxaban compared to LMWHs in treating cancer-associated VTE.MethodsFollowing ...